NAUT
Income statement / Annual
Last year (2023), Nautilus Biotechnology, Inc.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2023, Nautilus Biotechnology, Inc.'s net income was -$63.68 M.
See Nautilus Biotechnology, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
| Operating Revenue |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Cost of Revenue |
$5.71 M |
$3.42 M |
$2.84 M |
$2.35 M |
$0.00 |
$0.00 |
| Gross Profit |
-$5.71 M |
-$3.42 M |
-$2.84 M |
-$2.35 M |
$0.00 |
$0.00 |
| Gross Profit Ratio |
0 |
0 |
0 |
0 |
0 |
0 |
| Research and Development
Expenses |
$47.25 M
|
$37.67 M
|
$29.35 M
|
$12.43 M
|
$8,488.00
|
$0.00
|
| General & Administrative
Expenses |
$28.90 M
|
$25.95 M
|
$21.15 M
|
$3.31 M
|
$1,622.00
|
$111.68 M
|
| Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$28.90 M
|
$25.95 M
|
$21.15 M
|
$3.31 M
|
$1,622.00
|
$111.68 M
|
| Other Expenses |
$0.00 |
-$122,000.00 |
$183,000.00 |
$125,000.00 |
$0.00 |
$0.00 |
| Operating Expenses |
$76.15 M |
$63.62 M |
$50.50 M |
$15.74 M |
$9,618.00 |
$111.68 M |
| Cost And Expenses |
$76.15 M |
$63.62 M |
$50.50 M |
$15.74 M |
$9,618.00 |
$111.68 M |
| Interest Income |
$12.55 M |
$5.82 M |
$329,000.00 |
$0.00 |
$0.00 |
$0.00 |
| Interest Expense |
$0.00 |
$5.82 M |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Depreciation &
Amortization |
$1.85 M
|
$3.42 M
|
$2.84 M
|
$2.35 M
|
$548,000.00
|
$738.28 M
|
| EBITDA |
-$74.30 M
|
-$54.51 M
|
-$47.47 M
|
-$13.27 M
|
-$9.56 M
|
$626.60 M
|
| EBITDA Ratio |
0 |
0 |
0 |
0 |
0 |
0 |
| Operating Income Ratio
|
0
|
0
|
0
|
0
|
0
|
0
|
| Total Other
Income/Expenses Net |
$12.48 M
|
$5.69 M
|
$183,000.00
|
$125,000.00
|
-$9.61 M
|
$738.28 M
|
| Income Before Tax |
-$63.68 M |
-$57.92 M |
-$50.32 M |
-$15.62 M |
-$9,618.00 |
$626.60 M |
| Income Before Tax Ratio
|
0
|
0
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
$0.00 |
$5.82 M |
$2.61 M |
$2.14 M |
-$171,312.00 |
$738.12 M |
| Net Income |
-$63.68 M |
-$63.74 M |
-$50.32 M |
-$15.62 M |
-$9,618.00 |
$626.60 M |
| Net Income Ratio |
0 |
0 |
0 |
0 |
0 |
0 |
| EPS |
-0.51 |
-0.51 |
-0.6 |
-0.52 |
-0.0013 |
87.18 |
| EPS Diluted |
-0.51 |
-0.51 |
-0.6 |
-0.52 |
-0.0013 |
87.18 |
| Weighted Average Shares
Out |
$124.92 M
|
$124.59 M
|
$84.46 M
|
$29.96 M
|
$7.19 M
|
$7.19 M
|
| Weighted Average Shares
Out Diluted |
$124.92 M
|
$124.59 M
|
$84.46 M
|
$29.96 M
|
$7.19 M
|
$7.19 M
|
| Link |
|
|
|
|
|
|
